Source: https://www.law.cornell.edu/uscode/text/21/399g
Timestamp: 2018-07-22 20:42:34
Document Index: 261499636

Matched Legal Cases: ['§ 399', '§ 399', '§ 399', '§\u202f399', '§\u202f1014', '§\u202f3073']

21 U.S. Code § 399g - Food and Drug Administration Intercenter Institutes | US Law | LII / Legal Information Institute
U.S. Code › Title 21 › Chapter 9 › Subchapter X › § 399g
21 U.S. Code § 399g - Food and Drug Administration Intercenter Institutes
§ 399g.
(a) In generalThe Secretary shall establish one or more Intercenter Institutes within the Food and Drug Administration (referred to in this section as an “Institute”) for a major disease area or areas. With respect to the major disease area of focus of an Institute, such Institute shall develop and implement processes for coordination of activities, as applicable to such major disease area or areas, among the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Devices and Radiological Health (for the purposes of this section, referred to as the “Centers”). Such activities may include—
streamlining, where appropriate, the review of medical products to diagnose, cure, mitigate, treat, or prevent the specific diseases relevant to the major disease area of focus of the Institute, applying relevant standards under sections 355, 360(k), 360c(f)(2), and 360e of this title and section 262 of title 42, and other applicable authorities;
(June 25, 1938, ch. 675, § 1014, as added Pub. L. 114–255, div. A, title III, § 3073(a), Dec. 13, 2016, 130 Stat. 1136.)